KDKübra Daniş

Kübra Daniş

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Kübra Daniş has a total of 4 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Effect of Fisetin on the Expression of Some Age-Related Genes

    by Kübra Danış, Ayşe Gül Mutlu, Ali Kıyak

  • Open Access

    Senolytics and Their Effects on Various Diseases

    by Kübra Danış Oruç, Ayşe Gül Mutlu

    Senescence is the result of a process that is physiological for cells. With aging, there is an increase in the number of senescent cells in organisms, and these cells produce a number of compounds known as senescence-associated secretory phenotype (SASP). These compounds secreted by senescent cells cause healthy cells in the microenvironment to exposure senescence. Therefore, preventing the accumulation of senescent cells in tissues is important for healthy cells. Senolytics are compounds that can specifically eliminate senescent cells. One of the most important differences between a cell in its normal physiological process and a senescent cell is that senescent cells are resistant to apoptosis. Although senolytics have different mechanisms of action, they jointly target the anti-apoptotic pathways of the cells and the compounds in these pathways, thereby enabling the senescent cells to undergo apoptosis and be destroyed. In addition, accumulation of senescent cells in tissues increases the risk of susceptibility to various chronic diseases, especially cardiovascular diseases, neurodegenerative diseases, cancer and kidney diseases. Therefore, it is forecasted that inhibiting the accumulation of senescent cells in tissues may reduce the risk of disease. In this review study, the effects of senolytic compound examples such as Dasatinib, Quercetin, Navitoxlac (ABT-263) and Fisetin on cardiovascular diseases, neurodegenerative diseases, cancer, kidney diseases and inflammation were briefly summarized.

  • Production of biological hydrogen and bacterial carotenoids with Rhodobacter sphaeroides O.U.001 in a biorefinery concept

    by Kübra Daniş, Buse Nur Bi̇nGöl, Gökhan Kars

    In this study, the goal was to produce biohydrogen and bacterial carotenoids with Rhodobacter sphaeroides O.U.001, a purple non-sulfur photosynthetic bacterium, utilizing sugar beet molasses in the context of biorefinery. First, media with different sugar concentrations (10 g/L, 20 g/L, 30 g/L, 40 g/L, 50 g/L) were prepared for bacterial growth. Then, hydrogen production was carried out using these media in anaerobic conditions in 100 ml bioreactors. After hydrogen gas was collected from the bioreactors, carotenoid extraction was performed from the remaining bacteria. As a result of the analyzes, it was found that the amount of biohydrogen and the amount of bacterial carotenoids obtained were inversely proportional to the increased sugar concentrations. The maximum hydrogen formation was detected in the medium containing 10 g/L of sugar (19.18 mL). According to the results of gas chromatography analysis, the quantity of hydrogen in the total gas was found to be around 23.6%. The highest yield of carotenoids was again obtained from bacteria reproduced in a medium containing 10 g/L of sugar (3.12 mg/g, carotenoid/dry biomass). As a conclusion, this study provides an example for the successful realization of two high value-added products within a biorefinery approach by using molasses obtained at an affordable cost.